In one paragraphArticle in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Katarzyna Jóźwik-PlebanekDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.ORCID 0000-0002-6756-5415 Marek SaracynDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.ORCID 0000-0002-5800-0500 Maciej KołodziejDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.ORCID 0000-0003-1943-264X Weronika MądraDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.ORCID 0009-0001-1050-2704 Adam Daniel DurmaDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.ORCID 0000-0001-7103-2577 Mirosław DziukNuclear Medicine Department, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.ORCID 0000-0001-9993-373X Zuzanna BalcerskaDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
Katarzyna JaniakDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
Katarzyna Gniadek-OlejniczakNeurorehabilitation Clinic, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.ORCID 0000-0001-8837-8160 Grzegorz KamińskiDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.ORCID 0000-0002-2357-0634 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
177-Lu90-Yadverse eventscardiotoxicitycomplicationsNENneuroendocrine neoplasmsneuroendocrine tumorspeptide receptor radionuclide therapyPRRTRLT
Identifiers
PMID41097745
PMCPMC12524008
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390